List of works by Lenka Novakova

Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis

scientific article published on 27 October 2016

Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.

scientific article

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis

scientific article published on 21 November 2019

Clinically isolated syndromes with no further disease activity suggestive of multiple sclerosis at the age of population life expectancy

scientific article published on 18 July 2013

High Interferon-γ Uniquely in Vδ1 T Cells Correlates with Markers of Inflammation and Axonal Damage in Early Multiple Sclerosis

scientific article published on 09 March 2017

Inflammation-related plasma and CSF biomarkers for multiple sclerosis

scientific article published on 26 May 2020

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

scientific article published on 27 October 2017

Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.

scientific article published on 29 August 2015

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy

scientific article

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

scientific article published on 31 March 2016

Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers.

scientific article

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone

Paulina is supported by:

About Paulina

Help